eHealth (EHTH) Q2 2024 earnings summary

Executive summary

• Q2 2024 was marked by strong Medicare segment growth, with a 16% year-over-year increase in submissions and improved segment profit, while total approved members declined 7% due to non-Medicare product declines and Amplify model changes.

• Total Q2 2024 revenue was $65.9M, down 1% year-over-year, but non-GAAP revenue excluding net adjustment revenue rose 13% year-over-year.

• CEO and CFO transitions were announced, with succession plans in place and continued board involvement.

• Ongoing transformation efforts include enhanced member retention, new technologies, and a shift to fee-based BPO models for Amplify customers.

• Preparations for the 2025 Annual Enrollment Period include new retention and engagement tools and operational enhancements.

Financial highlights

• Q2 2024 GAAP net loss was $28.0M, up from $23.5M last year; adjusted EBITDA was $(15.5)M vs. $(14.8)M, and non-GAAP net loss improved year-over-year.

• Q2 2024 commission revenue fell 6% year-over-year to $56.8M, while non-commission/other revenue grew 37% to $9.0M, driven by Amplify's fee-based BPO platform.

• Operating cash flow was $(32.2)M in Q2, mainly due to higher bonus payouts and deferred revenue timing.

• Cash, cash equivalents, and marketable securities totaled $151.1M as of June 30, 2024.

• Commissions receivable balance was $831.9M at quarter end, up from $789.6M a year ago.

Outlook and guidance

• 2024 revenue guidance raised to $470M–$495M (prior: $450M–$475M), with adjusted EBITDA guidance increased to $7.5M–$25M and operating cash flow guidance improved to $(10)M to $0M.

• GAAP net loss guidance improved to $(36.5)M to $(22)M.

• Tail/net adjustment revenue for 2024 now expected at $14M–$20M.

• Non-GAAP total revenue excluding net adjustment revenue expected to grow ~15% year-over-year.

• Employer & Individual segment enrollment growth expected to resume in Q4 2024 after operational enhancements.